Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$1.29 – $1.83
84% from low
Borrow rate
10.14%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $3.7M | $5.3M | $19.4M | $6.8M | $12.0M |
| Cost of revenue | $8.3M | $15.7M | $0 | $0 | $3.5M | $0 |
| Gross profit | −$8.3M | −$12.0M | $5.3M | $19.4M | $3.3M | $12.0M |
| Gross margin | — | -319.0% | 100.0% | 100.0% | 48.6% | 100.0% |
| R&D | $8.3M | $15.7M | $36.9M | $40.1M | $32.6M | $28.4M |
| Operating income | −$9.6M | −$14.7M | −$43.6M | −$34.8M | −$43.4M | −$29.7M |
| EBITDA | −$9.5M | −$14.5M | −$41.0M | −$30.8M | −$40.5M | −$23.5M |
| Net income | −$9.7M | −$15.9M | −$42.4M | −$31.9M | −$41.9M | −$25.1M |
| Net margin | — | -425.1% | -791.7% | -164.5% | -618.6% | -209.6% |
| EPS (diluted) | -21.65 | -39.90 | -2.14 | -1.23 | -1.57 | -0.94 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $23M | $-0.54 | $-0.54–$-0.54 | 1 |
| 2027 | $4M | $-0.41 | $-0.41–$-0.41 | 1 |
| 2028 | $26M | $-0.25 | $-0.25–$-0.25 | 1 |
| 2029 | $61M | $-0.25 | $-0.25–$-0.25 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds LVTX.
No tracked institution reports a position in LVTX as of their last filing.
No one on the platform has traded LVTX yet.
| $42M |
| — |
| LTRNLantern Pharma Inc. | $4.07 | +5.44% | $52M | — |
| PDSBPDS Biotechnology Corporation | $0.90 | +1.19% | $50M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 6.3× sales vs its 6.5× historical median P/S.
Fair value ≈ $1.79 · price $1.74 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$LVTX pre revenue biotech where money goes to die
View on StockTwits ↗$LVTX Valuation sensitivity is high because visibility is uneven; organic growth must prove sustainable without incentives — clear evidence of repeatability would change the narrative. Durability will separate winners from speculation.
View on StockTwits ↗$LVTX 07:52 on Nov. 21 2025 XOMA Royalty Completes Acquisition Of LAVA Therapeutics With $1.04 Per Share Cash And CVR, Securing 91.1% Tendered Shares And Initiating Nasdaq Delisting Of LAVA #tradeideas
View on StockTwits ↗$XOMA completes acquisition of $LVTX https://www.globenewswire.com/news-release/2025/11/21/3192735/7281/en/XOMA-Royalty-Announces-Closing-of-Transactions-to-Acquire-LAVA-Therapeutics-N-V.html
View on StockTwits ↗$LVTX / $XOMA – Subsequent Offer Period Expires MergerBrief.com For Full Schedule
View on StockTwits ↗$LVTX NASDAQ Equity Corporate Actions Alert # 2025 - 611 Information Regarding the Tender Offer of LAVA Therapeutics N.V. (LVTX) https://www.nasdaqtrader.com/TraderNews.aspx?id=eca2025-611 The initial tender offer by $XOMA to acquire all of the outstanding common stock of $LVTX expired one minute after 11:59 p.m. ET, November 12, 2025. A subsequent offering is scheduled to expire one minute after 11:59 p.m. ET, November 20, 2025, unless extended or terminated. The subsequent merger is tentatively scheduled to close prior to the market open on November 21, 2025. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on November 20, 2025. If the merger closes as planned, the stock will remain halted on the day of closing (November 21st) and will be suspended effective November 24, 2025. At closing, LVTX shareholders will receive $1.04 and 1 CVR for each share held.
View on StockTwits ↗$LVTX bye! $PFE is licking their lips. Back door unlimited access? 😁
View on StockTwits ↗EOD CONTINUATION FOLLOW-UP – 10/22/25 Tracking continuation watchlist from yesterday based on intraday highs vs. close ⚠️ $INDO – Moving sideways, no significant momentum. Neutral. ⚠️ $LVTX – Moving sideways, holding range without breakout. Neutral. ⚠️ $COYA – Moving sideways, low volatility session. Neutral. ✅ $BIOA – Closed 6.08, reached HOD 8.60 (+41%). Strong continuation with heavy range expansion. ✅ $XTKG – Closed 2.04, hit HOD 2.20 (+7.8%). Clean follow-through with steady volume. Recap: 5 total → 2 winners ($BIOA, $XTKG), 0 fails, 3 neutral → 40% accuracy Leaders: $BIOA showed strongest momentum and volume-driven continuation; $XTKG held trend cleanly. Others remain flat awaiting confirmation. #vwap #smallcaps #daytrading #eodfollowup #continuation #snipersetup #accountability
View on StockTwits ↗EOD CONTINUATION WATCHLIST – 10/22/25 Focused on stocks that held VWAP and pushed into Power Hour with strength $INDO – 2.1x volume, 1.8% VWAP stretch, micro float (9.5M) 6.4% open-to-current with 7.2% late push, RSI 53.4. Watching breakout > 3.04 for continuation. $LVTX – 2.8x volume, 9.2% VWAP stretch, micro float (5.8M) 11.6% open-to-current with 11.6% late push, RSI 68.3. Watching breakout > 1.64 for continuation. $COYA – 2.8x volume, 0.9% VWAP stretch, small float (12.6M) 7.0% open-to-current with 2.0% late push, RSI 46.0. Watching breakout > 7.55 for continuation. $BIOA – 3.7x volume, 1.0% VWAP stretch, small float (24.3M) 6.2% open-to-current with 0.3% late push, RSI 46.1. Watching breakout > 6.11 for continuation. $XTKG – 6.2x volume, 0.6% VWAP stretch, small float (36.0M) 6.3% open-to-current with 0.5% late push, RSI 41.9. Watching breakout > 2.08 for continuation. #eod #vwap #momentum #smallcaps #daytrading #continuationsetups #powerhourwatch
View on StockTwits ↗$LVTX quick jump in price could indicate afternoon PR, keep an eye on this
View on StockTwits ↗$ADVB walk it up with bids $MNTS 1.25 bid $ACDC consolidating $LVTX one more down 🍫 $BCG Top play this week, everyones on it it seems. Get ur trade off.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.